Soft tissue and altered biomechanics in patients with a high BMI can make surgical exposure and component placement more challenging, leading to prolonged operative times
Popular GLP-1 Receptor Agonists Some of the well-known GLP-1 receptor agonists include: There are four GLP-1 agonist medicines approved by the Therapeutic Goods Administration (TGA) for use in Australia for the management of Type 2 Diabetes: dulaglutide (Trulicity) semaglutide (Ozempic) tirzepatide (Mounjaro) liraglutide (Saxenda)
Understanding obesity as a chronic, relapsing illness GLP-1s fold into the treatment conversation for obesity because the cultural discourse around obesity is changing
Should this prospect be dismissed, an exhaustive exploration of other potential culprits is imperative, including systemic causes (both hepatic and extrahepatic), neurological disorders, and psychogenic triggers (20)
Upstream benefits: FDA has just approved a new use for Wegovy to reduce the risk of adverse cardiovascular events
RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
